Affinity Group
Co-chaired by Dr. Pergam and Dr. Liu, the affinity group “Infectious Diseases in the Immunocompromised Host” is a new speaking series on a topic of the speaker’s choice, related to immunocompromised hosts. The lectures are typically 30 minutes, followed by a 30 minute Q&A. This speaking series is an informal event, meant to foster novel collaborations, present new research ideas and to enhance understanding within our niche research community.
June 4th Affinity Group - Career Pathways in Infectious Disease
Affinity Group speakers Dr. Ison and Dr. Chin-Hong with co-chairs Dr. Pergam and Dr. Liu
Affinity Group speakers Dr. Ison and Dr. Chin-Hong with the group.
Cross collaboration
Dr. Sanjeet Dadwal and Zahra Eftekhari (City of Hope) speak to fellows, clinical coordinators, and students regarding machine-learning based sepsis prediction in stem cell transplants.
Peter Chin-Hong in conversation.
Mentoring dinner with Dr. Eric Lofgren after his talk "Dirty Doctors and Pestilent Puppies: Modeling Infection Control at the Human Animal Interface"
Dr. Lofgren in conversation with fellows, clinical coordinators, and students
Elizabeth Gulleen, MD (Fred Hutch) l December 2, 2019
The Exception as the Rule -Antimicrobial Resistance and Stewardship in Patients with Leukemia
Sam Aitken, PharmD (MD Anderson) l August 16, 2019
Multidrug Resistant Bacteria: Common Cause of Neutropenic Fever and Mortality Among Patients with Hematologic Malignancies in Uganda
Maggie Lubwama (Uganda Cancer Institute) l June 13, 2019
Machine-Learning Based Sepsis Prediction in Stem Cell Transplant Recipients
Sanjeet Dadwal, MD (City of Hope) l June 7, 2019
Beta Lactam and Other Antibiotic Allergies in Patients Undergoing Solid Organ and Hematopoietic Cell Transplantation
Hannah Imlay, MD (University of Washington) l May 15, 2019
Identifying Sepsis in Hematopoietic Cell Transplant Recipients with Diagnostic Criteria, a Look at Current Standards and Future Opportunities
Maggie Lind, PhD Candidate (University of Washington) l April 25, 2019
Impact of fluoroquinolone neutropenic prophylaxis on the antimicrobial susceptibility and epidemiology of invasive Pseudomonas aeruginosa infections
Morgan Hakki, MD (Oregon Health and Science University) l March 11, 2019
Mutual interaction between respiratory virus infections and antibiotics
Chikara Ogimi, MD (Seattle Children's) l November 8, 2018
Demystifying the Antibiotic Allergy Evaluation
Lahari Rampur, MD (University of Washington) l October 29, 2018
Viral GI Pathogens in Transplantation
Dr. Michael Ison (Northwestern) l September 20, 2018
Dirty Doctors and Pestilent Puppies: Modeling Infection Control at the Human Animal Interface
Dr. Eric Lofgren (Washington State University) l July 5, 2018
Career Pathways in Infectious Disease
Dr. Michael Ison (Northwestern) and Dr. Peter Chin-Hong (UCSF) l June 4, 2018
Integrative Diagnosis of Invasive Fungal Sinusitis: Opportunities for Quality Improvement
Dr. Andrew Bryan (University of Washington) l April 23, 2018
Do Individualized Antibiotic Plans (IAPs) impact outcomes for BMT patients?
Dr. Scott Weissman (Seattle Children's) | Jan. 23, 2018
New Frontiers in Antibiotic Stewardship
Dr. Erica Stohs, Pergam Group | Dec. 14, 2017
Mucormycosis and Hospital Linens: Insights from an Investigation
Dr. Hong Nguyen (University of Pittsburg) | Nov. 6, 2017
Influenza Vaccines in the Immunocomromised Host
Dr. Natasha Halasa, Vanderbilt l August 25, 2017
Improving Outpatient Care and Reducing Healthcare Resource Utilization in AML
Dr. Anna Halpern | Aug. 7, 2017
The Challenge of Preventing Infectious Disease in HSCT Patients in a Tropical Country
Dr. Silvia Costa, Hospital das Clinicas, University of Sao Paulo, Brazil | June 21, 2017
© 2021 Fred Hutchinson Cancer Research Center, a 501(c)(3) nonprofit organization.